RxDoctor Payments Data

Katelynn Timony, PA

Physician Assistant · Hackettstown, NJNPI 1205447968

Payments from drug & device makers

$1,424in general payments, 2019–2025

Across 70 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$502
  • Novo Nordisk$266
  • Lilly USA, LLC$89
  • Amarin Pharma, Inc.$89
  • GSK$80
  • Amgen$77
  • plus $320 from 11 others

What the payments were for

  • Food & beverage$1,424100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,424 in reported general payments places this provider in the 80th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$48,729
Medicare patients
164
Services billed
567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$20,488
Fiasp FlextouchInsulin Aspart (Niacinamide)17$17,622
EliquisApixaban15$13,131
FarxigaDapagliflozin Propanediol12$6,156
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$2,436
Albuterol Sulfate HfaAlbuterol Sulfate46$1,516
Levothyroxine Sodium78$1,002
Labetalol Hcl13$854
Celecoxib12$849
Atorvastatin Calcium107$811
Sertraline Hcl41$718
Clotrimazole21$665
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$662
Gabapentin22$534
Metoprolol Succinate41$506

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$266$20,48815 claims
PfizerEliquis$47$13,13115 claims
AstraZenecaFarxiga$502$6,15612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Hackettstown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →